Vijay Ulaganathan

Vijay Ulaganathan is an Associate Professor at Université de Lorraine, France. His research focuses on phosphotyrosine signaling pathways and genetic variants linked to autoimmune diseases and cancer. He combines synthetic biology and animal models to study molecular mechanisms of disease progression.

Education:

• B.Pharm (Pharmacy), Tamil Nadu Dr. M.G.R Medical University, Chennai, India
• M.Tech (Biological Sciences & Bioengineering), IIT Kanpur, India
• PhD (Autoimmunity), LMU Munich/Max Planck Institute of Neurobiology, Germany

Professional Experience:

• 2010-2011: Post-doc (Kinase Signaling in Cancer Progression), Max Planck Institute of Biochemistry
• 2012-2018: Project Leader (Genetic variants of tyrosine phosphorylation), Max Planck Institute of Biochemistry
• 2018-2021: Research Group Leader (Phosphotyrosine-altering genetic variants in immune signaling pathways), Universitätsmedizin Göttingen

Current Research: Investigating molecular basis of phosphotyrosine-altering genetic variants in complex diseases. Active in M2 thesis supervision on computational tools for tyrosine phosphorylation analysis and STAT3 receptor variant roles in cell metabolism.

Labs/Teams: Member of Team 1 at Campus Brabois Santé, Université de Lorraine